Chronic intracerebroventricular infusion of lipopolysaccharide: Effects of ibuprofen treatment and behavioural and histopathological correlates

Behavioural Pharmacology

Volumn 16, Issue 7, 2005, Pages 531-541

  Richardson, R L ^a,c   Kim, E M ^a   Gardiner, T ^b   O'Hare, Eugene ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c DUBLIN BUSINESS SCHOOL   (Ireland)

Author keywords

Alzheimer's disease; Cyclic ratio schedule; Inflammation; Lipopolysaccharide; Operant behaviour; Rat

Indexed keywords

AMYLOID; IBUPROFEN; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BEHAVIOR DISORDER; CELL ACTIVATION; CEREBROSPINAL FLUID; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; HISTOPATHOLOGY; MALE; MICROGLIA; NONHUMAN; OSMOTIC PUMP; RAT; REINFORCEMENT;

AMYLOID BETA-PROTEIN; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS; ASTROCYTES; BEHAVIOR, ANIMAL; BRAIN; FOOD; GLIAL FIBRILLARY ACIDIC PROTEIN; IBUPROFEN; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; LIPOPOLYSACCHARIDES; MALE; MEMORY; MICROGLIA; NEUROFIBRILLARY TANGLES; RATS; RATS, WISTAR; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE;

EID: 26244465522     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fbp.0000179278.03868.96     Document Type: Article

References (52)

1. Akiyama H, Kawamata T, Dedhar S, McGeer PL (1991). Immunohistochemical response in Alzheimer's disease. J Neuroimmunol 32:19-28.
2. Andersen K, Launer LJ, Ott A (1995). Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam study. Neurology 45:1441-1445.
3. Aubert A, Vega C, Dantzer R, Goodall G (1995). Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Behav Immun 9:129-148.
4. Bauer J, Ganter U, Strauss S, Stadmüller G, Frommberger U, Bauer H, et al. (1992). The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. Res Immunol 143:650-657.
5. Bluthe RM, Dantzer R, Kelley KW (1992). Effects of interleukin-1 receptor anatagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res 573:318-330.
6. Breitner JCS, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, et al. (1994). Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study. Neurology 44:227-232.
7. Broe GA, Henderson AS, Creasey H (1990). A case-control study of Alzheimer's disease in Australia. Neurology 40:1698-1707.
8. Brugg B, Dubreuil G, Huber G, Wollman EE, Delhaye-Bouchaud N, Mariani J (1995). Inflammatory processes induce β-amyloid precursor protein changes in mouse brain. Proc Natl Acad Sci USA 92:3032-3035.
9. Canning DR, McKeown RJ, DeWitt DA, Perry G, Wujek JR, Frederickson RC, et al. (1993). β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp Neurol 124:289-298.
10. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C (1993). Micrglia and cytokines in neurological disease, with special references to AIDS and Alzheimer's disease. Glia 7:75-83.
11. Duffy PE, Rapoport SI, Graf L (1980). Glial fibrillary acidic protein and Alzheimer's-type senile dementia. Neurology 30:778-782.
12. Eikelenboom P, Hack CE, Rozemuller JM, Stam FC (1989). Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Archiv B Cell Pathology 56:259-262.
13. French LR, Schuman LM, Mortimer JA, Hutton JT, Boatman RA, Christians B (1985). A case-control study of dementia of the Alzheimer's type. Am J Epidemiol 121:414-421.
14. Griffin WTS, Stanley LC, Ling C (1989). Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86:7611-7615.
15. Haga S, Akai K, Ishii T (1989). Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol (Berl) 77: 569-575.
16. Hansen LA, Armstrong DM, Terry RD (1987). An immunohistochemical quantification of fibrous astrocytes in the aging cerebral cortex. Neurobiol Aging 8:1-6.
17. Hatten ME, Leim RK, Shelanski ML, Mason CA (1991). Astroglia in CNS injury. Glia 4:233-243.
18. Hauss-Wegrzyniak B, Wenk GL (2002). Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle. Neurosci Lett 322:75-78.
19. Hauss-Wegrzyniak B, Hobrzanski P, Stoehr JD, Wenk GL (1998a). Chronic inflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res 780:294-303.
20. Hauss-Wegrzyniak B, Lukovic L, Bigaud M, Stoeckel ME (1998b). Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study. Brain Res 794:211.
21. Hoke A, Canning DR, Malemud CJ, Silver J (1994). Regional differences in reactive gliosis induced by substrate-bound β-amyloid. Exp Neurol 130: 56-66.
22. Ishii T, Haga S, Kametari F (editors) (1988). Presence of Immunoglobulins and Complements in the Amyloid Plaques in the Brain of Patients with Alzheimer's Disease. Berlin: Springer,
23. Itagaki S, McGeer PL, Akiyami H, Selkoe D (1989). Relationship of microglia and astrocytes to amyloid deposits of Alzheimer's disease. J Neuroimmunol 24:173-182.
24. Jenkinson ML, Bliss MR, Brain AT, Scott DL (1988). Rheumatoid arthritis and senile dementia of the Alzheimer's type. Br J Rheumatol 28: 86-88.
25. Lacosta S, Merali Z, Anisman H (1999). Behavioral and neurochemical effects of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res 818:291-303.
26. Mackenzie IRA, Munoz DG (1998). Nonsteroidal anti-inflammatory drug use in Alzheimer-type pathology in aging. Neurology 50:986-990.
27. Mandybur TI, Chuirazzi BA (1990). Astrocytes and the plaques of Alzheimer's disease. Neurology 40:635-639.
28. McGeer PL, McGeer EG (1995). The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21:195-218.
29. McGeer PL, McGeer EG (1996). Immune mechanisms in neurodegenerative disorders. Drugs Today 32:149-158.
30. McGeer PL, Rogers J (1992). Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42:447-449.
31. McGeer PL, Akiyama H, Itagaki S, McGeer EG (1989a). Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 107:341-346.
32. McGeer PL, Akiyama H, Itagaki S, McGeer EG (1989b). Immune system response in Alzheimer's disease. Can J Neurol Sci 16:516-527.
33. McGeer PL, McGeer EG, Rogers J, Sibley J (1990). Anti-inflammatory drugs and Alzheimer's disease. Lancet 335:1037.
34. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG (1993). Microglia in degenerative neurological disease. Glia 7:84-92.
35. McGeer PL, Walker DG, Haruhiko A, Yasuhara O, McGeer EG (1994). Involvement of microglia in Alzheimer's disease. Neuropath Appl Neurobiol 20:191-192.
36. Myllykangas-Luosujarvi R, Isomaki H (1994). Alzheimer's disease and rheumatoid arthritis. Br J Rheumatol 33:501-502.
37. Netland EE, Newton JL, Majocha RE, Tate BA (1998). Indomethacin reverses the microglial response to amyloid β-protein. Neurobiol Aging 19:201-204.
38. O'Hare E, Weldon DT, Mantyh PW, Ghilardi JR, Finke MP, Kuskowski MA, et al. (1999). Delayed behavioral effects following intrahippocampal injection of aggregated Aβ(1-42). Brain Res 815:1-10.
39. Paxinos G, Watson C (1996). The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
40. Pike CJ, Cummings BJ, Monzavi R, Cottman CW (1994). β-Amyloid induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63:517-531.
41. Pugh CR, Kumagawa K, Fleshner M, Watkins LR, Maier SF, Rudy JW (1998). Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav Immun 12:212-229.
42. Quan N, Sundar SK, Weiss JM (1994). Induction of interleukin-1 in brain regions after peripheral and central injections of lipopolysaccharide. J Neuroimmunol 49:125-134.
43. Richardson RL, Kim E-M, Shephard RA, Gardiner T, Cleary J, O'Hare E (2002). Behavioural and histopathological analyses of ibuprofen treatment on the effect of aggregated Aβ(1-42) injections in the rat. Brain Res 954:1-10.
44. Rogers J, Luber-Narod J, Styren SD, Civin WH (1988). Expression of immune system associated antigen by cells of the human central nervous system. Relation to the pathology of Alzheimer's disease. Neurobiol Aging 9:330-349.
45. Sheng GK, Mrak RE, Griffin WS (1995). Microglial interleukin 1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol Appl Neurobiol 21:290-301.
46. Sigurdsson EM, Lorens SA, Hejna MJ, Dong XW, Lee JM (1996). Local and distant histopathological effects of unilateral amyloid-β 25-35 injections into the amygdala of young F344 rats. Neurobiol Aging 17:893-901.
47. Sigurdsson EM, Lee JM, Dong XW, Hejna MJ, Lorens SA (1997). Bilateral injections of amyloid-β 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects. Neurobiol Aging 18:591-608.
48. Stewart WF, Kawas C, Corrada M, Metter EJ (1997). Risk of Alzheimer's disease and duration of NSAID use. Neurology 48:626-632.
49. Szczepanik AM, Fishkin RJ, Rush DK, Wilmot CA (1996). Effects of chronic intrahippocampal infusion of lipopolysaccharide in the rat. Neuroscience 70:57-65.
50. Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, et al. (1997). Molecular and cellular characterization of the membrane attack complex C5b-9, in Alzheimer's disease. Neurobiol Aging 18:415-421.
51. Weldon DT, O'Hare E, Kuskowski MA, Cleary J, Mach JR Jr (1996). Alternating lever cyclic-ratio schedule analysis of the effects of atropine sulfate. Pharmacol Biochem Behav 54:753-757.
52. Weldon DT, Rogers SD, Ghilardi JR, Finke MP, Cleary JP, O'Hare E, et al. (1998). Fibrillar β-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci 18:2161-2173.